There is a version of selectivity that is just failure dressed up in better language. A fund that does few deals because it cannot source good ones, or because its team lacks the credibility to win competitive situations, is not being disciplined. It is being outcompeted and calling the outcome a strategy. That version exists, and it is worth naming, because it has given the real thing a credibility problem.
The real thing looks different, and the distinction matters in a market where deal volume has become a proxy for health and activity a substitute for judgment.
In most institutional contexts, a GP is rewarded for deployment. Raising a fund creates pressure to put capital to work, and the fee structure of a conventional private equity firm aligns the manager’s income with assets under management rather than outcomes. A firm deploying faster is, in most fee structures, a firm earning more. That incentive is not hidden. It is the standard architecture of the business, and it shapes behavior in ways that are predictable once you see them clearly. The deals that shouldn’t have been done but were done anyway, because the fund needed to be invested, are not anomalies in this model. They are the expected output of it.
A principal-led firm operating its own capital alongside outside investors is not insulated from this entirely, but the tension is different. When the people making investment decisions are writing checks from their own accounts alongside the fund, the cost of a bad decision lands differently than when carried interest is the primary financial stake. There is no deployment incentive to rationalize a deal that shouldn’t be done. There is no vintage year pressure from an LP base watching commitment pacing. The question in front of every opportunity is simpler and harder: do we actually want to own this, with these people, at this price, for the next several years?
A small deal count, evaluated honestly, is evidence of that question being asked and answered consistently. It means some things that looked attractive did not clear the bar on people or fit or conviction. In a market where the volume of capital chasing lower middle market deals has pushed many firms toward broader mandates and more permissive underwriting, the willingness to pass is neither a limitation nor a brand position. It is the actual mechanism by which the standard stays where it belongs.
The irony is that selectivity reads as a liability precisely when it is most valuable. When deal flow is abundant and capital is cheap, volume strategies can outperform simply by being present across more transactions. When markets tighten, when diligence reveals what frothy conditions obscured, and when exits require real operational work rather than multiple expansion, the firms that own fewer, better businesses with more aligned counterparties tend to find the path forward cleaner. The market has been moving toward that test for several years now.
